Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals

Li Liu, Shefali Oza, Dan Hogan, Yue Chu, Jamie Perin, Jun Zhu, Joy E Lawn, Simon Cousens, Colin Mathers, Robert E Black, Li Liu, Shefali Oza, Dan Hogan, Yue Chu, Jamie Perin, Jun Zhu, Joy E Lawn, Simon Cousens, Colin Mathers, Robert E Black

Abstract

Background: Despite remarkable progress in the improvement of child survival between 1990 and 2015, the Millennium Development Goal (MDG) 4 target of a two-thirds reduction of under-5 mortality rate (U5MR) was not achieved globally. In this paper, we updated our annual estimates of child mortality by cause to 2000-15 to reflect on progress toward the MDG 4 and consider implications for the Sustainable Development Goals (SDG) target for child survival.

Methods: We increased the estimation input data for causes of deaths by 43% among neonates and 23% among 1-59-month-olds, respectively. We used adequate vital registration (VR) data where available, and modelled cause-specific mortality fractions applying multinomial logistic regressions using adequate VR for low U5MR countries and verbal autopsy data for high U5MR countries. We updated the estimation to use Plasmodium falciparum parasite rate in place of malaria index in the modelling of malaria deaths; to use adjusted empirical estimates instead of modelled estimates for China; and to consider the effects of pneumococcal conjugate vaccine and rotavirus vaccine in the estimation.

Findings: In 2015, among the 5·9 million under-5 deaths, 2·7 million occurred in the neonatal period. The leading under-5 causes were preterm birth complications (1·055 million [95% uncertainty range (UR) 0·935-1·179]), pneumonia (0·921 million [0·812 -1·117]), and intrapartum-related events (0·691 million [0·598 -0·778]). In the two MDG regions with the most under-5 deaths, the leading cause was pneumonia in sub-Saharan Africa and preterm birth complications in southern Asia. Reductions in mortality rates for pneumonia, diarrhoea, neonatal intrapartum-related events, malaria, and measles were responsible for 61% of the total reduction of 35 per 1000 livebirths in U5MR in 2000-15. Stratified by U5MR, pneumonia was the leading cause in countries with very high U5MR. Preterm birth complications and pneumonia were both important in high, medium high, and medium child mortality countries; whereas congenital abnormalities was the most important cause in countries with low and very low U5MR.

Interpretation: In the SDG era, countries are advised to prioritise child survival policy and programmes based on their child cause-of-death composition. Continued and enhanced efforts to scale up proven life-saving interventions are needed to achieve the SDG child survival target.

Funding: Bill & Melinda Gates Foundation, WHO.

Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Global causes of under-5 deaths in 2015
Figure 2
Figure 2
Global trends in cause-specific mortality rates in neonates and children aged 1–59 months, 2000–15 *About 61% of the reduction comes from pneumonia, diarrhoea, malaria, and measles among 1-59-month olds and neonatal intrapartum related events.
Figure 3
Figure 3
Cause-of-death mortality fractions (A) and cause-specific mortality rates (B) by U5MR strata, 2015 U5MR=under-5 mortality rate. U5MR strata are defined as very low (

References

    1. You D, Hug L, Ejdemyr S. Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Inter-agency Group for Child Mortality Estimation. Lancet. 2015;386:2275–2286.
    1. United Nations General Assembly . United Nations Millennium Declaration: Resolution. United Nations; New York: 2000. (accessed Aug 1, 2016).
    1. United Nations General Assembly . Transforming our world: the 2030 Agenda for Sustainable Development. United Nations; New York: 2015. (accessed Aug 1, 2016).
    1. United Nations . Sustainable Development Goals. United Nations; New York: 2015. (accessed Sept 11, 2015).
    1. You D, Hug L, Ejdemyr S, Beise J. Levels and trends in child mortality. Report 2015. Estimates developed by the UN Inter-agency Group for Child Mortality Estimation. United Nations Children's Fund; New York: 2015. (accessed Sept 8, 2015).
    1. United Nations Department of Economic and Social Affairs Population Division . World Population Prospects: The 2015 Revision, DVD Edition. United Nations; New York: 2015.
    1. Liu L, Oza S, Hogan D. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–440.
    1. Liu L, Johnson HL, Cousens S. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379:2151–2161.
    1. Mosley WH, Chen LC. An analytical framework for the study of child survival in developing countries. Popul Dev Rev. 1984;10:25–45.
    1. Rudan I, Chan KY, Zhang JS. Causes of deaths in children younger than 5 years in China in 2008. Lancet. 2010;375:1083–1089.
    1. He C, Liu L, Chu Y, et al. National and subnational levels and causes of child mortality in 1996-2015 in China: implications for the Sustainable Development Goals. Lancet Global Health (in press).
    1. Bhatt S, Weiss DJ, Cameron E. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–211.
    1. Lucero MG, Dulalia VE, Nillos LT. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev. 2009;4 CD004977.
    1. Davis S, Feikin D, Johnson HL. The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review. BMC Public Health. 2013;13:S21.
    1. Lamberti LM, Ashraf S, Walker CLF, Black RE. A systematic review of the effect of rotavirus vaccination on diarrhea outcomes among children under-five. Pediatr Infect Dis J. 2016;35:992–998.
    1. Hall P, Racine J, Li Q. Cross-validation and the estimation of conditional probability densities. Am Statist Assoc. 2011 published online Dec 31.
    1. Efron B. Second thoughts on the bootstrap. Stat Sci. 2003;18:135–140.
    1. Rajaratnam JK, Marcus JR, Flaxman AD. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970–2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet. 2010;375:1988–2008.
    1. Stevens GA, Alkema L, Black RE. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. PLoS Med. 2016;13:e1002056.
    1. Friedman HS. Causal inference and the Millennium Development Goals (MDGs): assessing whether there was an acceleration in MDG development indicators following the MDG declaration. Munich Personal RePEc Archive; 2013. (accessed March 1, 2016).
    1. Afnan-Holmes H, Magoma M, John T. Tanzania's Countdown to 2015: an analysis of two decades of progress and gaps for reproductive, maternal, newborn, and child health, to inform priorities for post-2015. Lancet Glob Health. 2015;3:e396–e409.
    1. Amouzou A, Habi O, Bensaïd K, Group NCCSW. Reduction in child mortality in Niger: a Countdown to 2015 country case study. Lancet. 2012;380:1169–1178.
    1. Bhutta ZA, Das JK, Walker N. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet. 2013;381:1417–1429.
    1. WHO . World Malaria Report 2014. World Health Organisation; Geneva: 2014. (accessed March 9, 2016).
    1. Lorenzetti L. World's first malaria vaccine, from GlaxoSmithKline, wins approval from EU. 2015. (accessed Sept 30, 2015).
    1. Black RE, Levin C, Walker N. Reproductive, maternal, newborn, and child health: key messages from Disease Control Priorities 3rd Edition. Lancet. 2016 published online April 9.
    1. WHO . WHO recommendations on interventions to improve preterm birth outcomes. World Health Organization; Geneva: 2015. (accessed March 9, 2016).
    1. Kamath-Rayne BD, Griffin JB, Moran K. Resuscitation and obstetrical care to reduce intrapartum-related neonatal deaths: a MANDATE study. Matern Child Health J. 2015;19:1853–1863.
    1. Lee AC, Cousens S, Wall SN. Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: a systematic review, meta-analysis and Delphi estimation of mortality effect. BMC Public Health. 2011;11:1.
    1. Lee AC, Cousens S, Darmstadt GL. Care during labor and birth for the prevention of intrapartum-related neonatal deaths: a systematic review and Delphi estimation of mortality effect. BMC Public Health. 2011;11:1.
    1. Alonge O, Hyder AA. Reducing the global burden of childhood unintentional injuries. Arch Dis Child. 2014;99:62–69.
    1. Horton R. Offline: The future for women's and children's health. Lancet. 2016;387:1982.
    1. Tshefu A, Lokangaka A, Ngaima S. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial. Lancet. 2015;385:1758–1766.
    1. Tshefu A, Lokangaka A, Ngaima S. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial. Lancet. 2015;385:1767–1776.
    1. WHO . Guideline: managing possible serious bacterial infection in young infants when referral is not feasible. World Health Organization; Geneva: 2015. (accessed March 9, 2016).
    1. Baqui AH, Saha SK, Ahmed ANU. Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open-label, equivalence trial. Lancet Glob Health. 2015;3:e279–e287.
    1. National Institute of Allergy and Infectious Diseases Questions and answers: the START HIV Treatment Study. 2015. (accessed March 9, 2016).
    1. WHO . Treat all people living with HIV, offer antiretrovials as additional prevention choice for people at “substantial risk”. New policies could help avert more than 21 million deaths and 28 million new infections by 2030. World Health Organization; Geneva: 2015. (accessed March 9, 2016).
    1. Wilson N. Can disease-specific funding harm health? in the Shadow of HIV/AIDS service expansion. Demography. 2015;52:1671–1700.
    1. Bassat Q, Ordi J, Vila J. Development of a post-mortem procedure to reduce the uncertainty regarding causes of death in developing countries. Lancet Glob Health. 2013;1:e125–e126.
    1. The Bill & Melinda Gates Foundation The Bill & Melinda Gates Foundation to fund disease surveillance network in Africa and Asia to prevent childhood mortality and help prepare for the next epidemic. Seattle, USA. 2015. (accessed Sept 30, 2015).
    1. Oestergaard MZ, Alkema L, Lawn JE. Millennium Development Goals national targets are moving targets and the results will not be known until well after the deadline of 2015. Int J Epidemiol. 2013;42:645–647.
    1. Ford L. Leaders pledge $25bn to improve health of women, children and adolescents. 2015. (accessed Sept 30, 2015).
    1. Glass RI, Guttmacher AE, Black RE. Ending preventable child death in a generation. JAMA. 2012;308:141–142.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe